NPR News14 sa önceSaludUnited States
New Treatments and Prevention Methods Tested in DRC and Uganda Ebola Outbreak
En resumen
- Over 50 days into the Ebola outbreak in DRC and Uganda, clinical trials are underway for new treatments against the rarer Bundibugyo virus.
- Two drugs, remdesivir and MBP-134, are being tested for treatment, while obeldesivir is being studied for post-exposure prevention.
- The trials face challenges including ongoing conflict and community mistrust.
Resumen generado por IA
Tamaño de fuente
Over 50 days into the Ebola outbreak in DRC and Uganda, clinical trials are underway for new treatments against the rarer Bundibugyo virus. Two drugs, remdesivir and MBP-134, are being tested for treatment, while obeldesivir is being studied for post-exposure prevention. The trials face challenges including ongoing conflict and community mistrust.
Temas relacionados
This article was originally published by NPR News.
